Exocrine Pancreatic Insufficiency clinical trials at UCSF
1 research study open to eligible people
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
open to eligible people ages 21 years and up
This is a study in participants with Exocrine Pancreatic Insufficiency (EPI) due to pancreatic cancer that has been resected. This study will include resected participants who are post pancreatic cancer surgery, and an additional cohort in non-resected participants.
Fresno, California and other locations